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Background: In this study the value of thrombin generation parameters measured by the Calibrated Automated
Thrombography for prediction of blood loss after cardiac surgery with cardiopulmonary bypass was investigated.
Methods: Thirty male patients undergoing first-time coronary artery bypass grafting were enrolled. Blood samples
were taken pre-bypass before heparinisation (T1) and 5 min after protamine administration (T2). Thrombin
generation was measured both in platelet-rich plasma and in platelet-poor plasma. Besides thrombin generation
measurements, activated clotting time, haematocrit, haemoglobin, platelet number, fibrinogen, antithrombin,
D-dimers, prothrombin time and activated partial thromboplastin time were determined. Blood loss was measured
and the amount of transfusion products was recorded postoperatively until 20 hours after surgery. Patients were
divided into two groups based on the median volume of postoperative blood loss (group 1: patients with median
blood loss <930 ml; group 2: patients with median blood loss ≥930 ml).
Results: On T1, patients of group 2 had a significantly lower endogenous thrombin potential and peak thrombin
(p<0.001 and p=0.004 respectively) in platelet-rich plasma, a significantly lower endogenous thrombin potential
(p=0.004) and peak thrombin (p=0.014) in platelet-poor plasma, and a lower platelet count (p=0.002). On T2 both
endogenous thrombin potential and peak thrombin remain significantly lower (p=0.011 and p=0.010) in group 2,
measured in platelet-rich plasma but not in platelet-poor plasma. In addition, platelet number remains lower in
group 2 after protamine administration (p=0.002).
Conclusions: The key finding is that the Calibrated Automated Thrombography assay, performed preoperatively,
provides information predictive for blood loss after cardiac surgery.
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Blood loss and thrombotic incidents still belong to the
most frequent and feared complications in cardiac sur-
gery with cardiopulmonary bypass (CPB) [1], despite of
preoperative evaluation of the haemostatic condition by
assessment of medical history and common coagulation
tests [2,3]. Disturbed haemostasis can be attributed to
abnormal thrombin generation (TG), platelet dysfunc-
tion and excessive fibrinolysis. Anticoagulation with high* Correspondence: yvonne.bosch@mumc.nl
1Department of Cardiothoracic Surgery, Cardiovascular Research Institute
Maastricht, Maastricht University Medical Center, P. Debeyelaan 25, PO Box
5800, 6202, AZ, Maastricht, the Netherlands
Full list of author information is available at the end of the article
© 2013 Bosch et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordoses of heparin may result in further haemostasis impair-
ment. Currently, tools to adequately predict haemostasis
and therefore to control blood loss are lacking. Although
it was already shown that the use of thromboelastography
(TEG) may help to reduce blood product consumption,
studies investigating the relationship between coagulation
tests, like TEG, haemostatic variables and bleeding are
inconsistent in demonstrating a clear predictive value for
the volume of blood loss after CPB [2,4,5]. In part, this
inconsistency may be due to the fact that TEG only shows
clot formation, not the total amount of thrombin, which
plays a central role in haemostasis [6].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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thrombin generation parameters as measured by the
Calibrated Automated Thrombography (CAT) [6] for the
prediction of blood loss after cardiac surgery. This assay
displays not only the moment blood starts to clot but also
the amount of thrombin that forms in clotting plasma
with or without platelets. Conceptually, results of CAT
measurements correlate with impaired haemostasis if too
low, and with thrombosis risk if too high [7,8]. CAT might
improve the timely identification of haemostatic problems
underlying a bleeding tendency perioperatively. In this
study, we hypothesize that CAT measurement, in com-
parison with conventional methods, may better predict
the risk of blood loss and the need for transfusion
products. Improved prediction could contribute to safer
anticoagulation, since CAT quantifies the (anti) coagu-
lant effects during CPB, to more optimal haemostasis,
to a decrease in excessive bleeding and to improved
transfusion management.Methods
Study population
The study was approved by the local medical ethics com-
mittee (METC aZM/UM), and written informed consent
was obtained. In total, 30 male patients undergoing elec-
tive first-time coronary artery bypass grafting (CABG)
were enrolled. Exclusion criteria were age < 18 years, use
of preoperative anticoagulation (excepting aspirin) within
the preceding 5 days, known coagulopathy, impaired renal
function, liver diseases resulting in elevated liver function
tests and redo surgery.Anticoagulation and CPB
An initial dose of 300 IU/kg of body weight of heparin
(Heparin Leo, Leo Pharmaceutical Products BV, Weesp,
the Netherlands) was injected into a central venous line
before initiation of CPB. The kaolin activated clotting
time (ACT) was measured and, if the value was ≥400 s,
CPB was initiated. If necessary, additional heparin was
added. At the end of CPB, heparin was reversed by
protamine chloride (Valeant Pharmaceuticals, Eschborn,
Germany) at a 1:1 ratio of the loading dose.
All components of the CPB system were poly-
2-methoxyethylacrylate coated (Terumo).
The priming of the CPB circuit included 1,300 ml of 4%
Gelofusine, 200 ml 20% mannitol, 100 ml 20% human
albumin, 50 ml 8.4% NaHCO3. and 6,500 IU heparin Leo.
Retrograde autologous priming was used in most of the
cases to reduce the priming volume by 200–500 ml,
resulting in less haemodilution. Normothermic perfusion
was used during CPB. Pericardial, pleural and residual
blood of the CPB circuit after termination of CPB was
drained and washed with a cell saver device. Thetransfusion trigger during CPB was set at a haematocrit
below 23%.
Blood samples
Blood samples were taken at: T1) pre-bypass before
heparin administration; and, T2) 5 min after protamine
administration. T1 measurements will give information
about the predictive value of the parameters prior to
haemostatic interventions related to CPB which could
suggest differences in baseline haemostatic capacity of
the blood between the patients, whereas T2 measure-
ments may give a prediction of blood loss after CPB
including the influence of all haemostatic disturbances
related to CPB. Blood samples were withdrawn from the
arterial line after discarding the first 10 ml.
Thrombin generation
Arterial blood samples were collected into trisodium cit-
rate and analyzed with CAT as previously reported [9]. TG
was measured both in platelet-rich plasma (PRP) and in
platelet-poor plasma (PPP) to see the influence of platelets
on TG. PRP was used within 1h after blood withdrawal.
PPP was stored at −80°C until further analysis. The CAT
assay was measured in a prewarmed plate fluorometer
(Ascent reader, Thermolabsystems OY, Helsinki, Finland).
To each well, 80 μl of plasma was added in combination
with the trigger: for PPP, the trigger was 30 pM of recom-
binant tissue factor (rTF) and phospholipid vesicles in
Hepes-buffered saline, for PRP the trigger was 20 μl of 3
pM of rTF without added phospholipids. Data were ana-
lyzed using Thrombinoscope™ software (Thrombinoscope
bv, Maastricht, the Netherlands). CAT parameters which
are used to determine correlation of TG with postoperative
blood loss are: 1) lag time (min): the initiation phase of clot-
ting which equals the clotting time; 2) peak height (nM):
the maximal amount of thrombin formed; 3) endogenous
thrombin potential (ETP) (nM*min): the area under the
curve representing thrombin generation and decay in time;
and 4) time to peak (min): the time needed to achieve the
peak height.
ACT and laboratory tests
Besides CAT measurements, ACT and laboratory parame-
ters haematocrit, haemoglobin, thrombocytes, fibrinogen,
antithrombin, D-dimers, prothrombin time (PT) and acti-
vated partial thromboplastin time (aPTT) were determined
at both time points to assess patient’s haemostatic profile.
Postoperative blood loss
Blood loss was measured at fixed time points postopera-
tively determined by chest tube drainage after closing
the chest until 20 hours after surgery. The amount of
transfusion products (packed red cells, thrombocytes
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after surgery.
Statistical analysis
Data were defined as continuous or categorical variables.
Categorical variables are expressed as percentages and
continuous variables as mean ± standard deviation (SD).
Patients were divided into two groups with high versus
low blood loss, where the median value of blood loss
volume at 20 hours postoperatively was used as cut-off
value. Both groups were compared with respect to pa-
tient characteristics, medication used pre- and intraoper-
atively, infusion solutions, mean time on bypass, amount
of transfusion products, mean values of CAT parameters
and other laboratory parameters. The Chi-square test
was used for comparison of proportions and the Stu-
dent’s t-test for independent samples for comparison of
mean values. The ability of CAT and laboratory parame-
ters to discriminate between the two groups was also
evaluated by the construction of a receiver operating
characteristic (ROC) curve. The corresponding area
under the curve (AUC) with 95% confidence interval was
used to quantify the predictive value of the parameters.
Multivariate linear regression analysis was performed to
evaluate the independent effects of parameters. StatisticalTable 1 Distribution of patient characteristics and perioperat
All patients
N=29
Age (years) 65 ± 10
Aspirin exp. preop. n (%) 27 (93,1%)
Intraoperatively
Tranexam. acid n (%) 14 (48,3%)
Heparin-total (IU/kg) 336 ± 54
Protamine-total (mg/kg) 3.35 ± 0.52
Crystalloids (ml/kg) 16.9 ± 6.5
Colloids (ml/kg) 18.6 ± 5.2
PRC (units)* 0.0 (0.0-1.0)
FFP (units) 0 ± 0
PLT (units)* 0.0 (0.0-1.0)
PRC cell saver (ml/kg) 5.7 ± 2.0
Time on bypass (min) 76 ± 20
Time X-clamp (min) 48 ± 16
Postoperatively
Blood loss 20 h (ml) 922 ± 384
PRC (units)* 1.00 (0.0-5.0)
FFP (units)* 0.0 (0.0-2.0)
PLT (units)* 0.0 (0.0-1.0)
Rethoracotomy n (%) 1 (3,4%)
Data shown are mean ± SD. Comparison between the groups was done with stude
colloids = infusion volume and priming volume; FFP fresh frozen plasma, PLT platelanalysis was performed with SPSS for Windows 16.0
(SPSS, Inc., Chicago, IL, USA). P-values ≤ 0.05 were con-
sidered to indicate statistical significance.
Results
Thirty male patients were enrolled into the study. One
patient was excluded because an exceptionally long term
adhesiolysis was necessary to achieve access to the heart
resulting in excess blood loss. The distribution of age,
preoperative use of aspirin, and intraoperative data relat-
ing to the 29 patients are shown in Table 1. In addition
to presenting data of the total group, we divided patients
in two groups using as cut-off value the median volume
of postoperative blood loss until 20 hours (group 1: pa-
tients with median blood loss <930 ml; group 2: patients
with median blood loss ≥930 ml). The actual blood loss
in group 1 was 620 ml, and 1205 ml in group 2. The
sample size was based on feasibility considerations.
Based on this sample size and the observed standard de-
viation in group 1 (sd= −/+ 160 ml) the power to detect
a clinically relevant increase in mean blood loss by at
least 50% (from 620 ml to 930 ml) was higher than 90%.
Differences in both medication and infusion (Table 1)
could result in changes in the haemostatic capacity of
the blood leading to differences in thrombin generationive variables according to postoperative blood loss
Group 1 Group 2 P-value
N=14 N=15
67 ± 9 64 ± 11 0.423
14 (100%) 13 (86,7%) 0.157
9 (64,3%) 5 (33,3%) 0.096
361 ± 66 314 ± 26 0.023
3.55 ± 0.61 3.17 ± 0.37 0.048
19.8 ± 6.4 14.2 ± 5.6 0.018
17.2 ± 4.8 19.9 ± 5.4 0.167
0.0 (0.0-1.0) 0.0 (0.0-1.0) 0.591
0 ± 0 0 ± 0 1
0.0 (0.0-1.0) 0.0 (0.0-0.0) 0.301
5.0 ± 1.3 6.4 ± 2.3 0.048
70 ± 18 81± 22 0.160
45 ± 14 52 ± 18 0.259
620 ± 160 1205 ± 307 <0.001
0.0 (0.0-2.0) 2.0 (0.0-2.0) 0.002
0.0 (0.0-0.0) 0.0 (0.0-2.0) 0.164
0.0 (0.0-0.0) 0.0 (0.0-1.0) 0.020
0 (0%) 1 (6,7%) 0.326
nt t-test; * median and range are presented instead of mean and SD;
ets, PRC packed red cells.
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nificant difference between aspirin exposure preopera-
tively between the two groups. Patients in group 2 were
infused less crystalloids, and more autologous packed
red cells derived from intraoperative cell salvage. More-
over, this group was administered less heparin (total
amount of both pre and during CPB) and as a conse-
quence less protamine. Time of bypass and aorta cross
clamping were increased in group 2, but differences were
not statistically significant.
Thrombin generation parameters measured in platelet-rich
and platelet-poor plasma
The mean values (± SD) of TG parameters on T1 and T2
in both PRP and PPP in group 1 versus group 2 are
presented in Table 2. Patients of group 2 had a signifi-
cantly lower ETP and peak thrombin both on T1 and T2.
Between group differences in mean values for lag time and
time to peak were smaller and not statistically significant.
The distributions of ETP and peak values measured in
PRP and PPP within groups are shown in Figures 1 and 2.
The AUCs as measures for ability to discriminate be-
tween the groups were highest for ETP and peak in PRP
at T1 with AUC (95% CI) of 0.881 (0.741-1.021) and 0.855
(0.697-1,013) respectively.
Laboratory tests
The mean values of haemoglobin, haematocrit, platelet
number, fibrinogen, d-dimers, antithrombin, PT, aPTT,
and ACT at T1 and T2 are shown in Table 3. A significantTable 2 TG parameters on T1 and T2, and their association w






Lag time (min) 8.7 ± 3.0 8.7 ± 3.2 7.9 ± 1.4 9.4 ± 3.8
ETP (nM* min) 1881 ± 359 1524 ± 264 2104 ± 207 1672 ± 348
Peak (nM) 133 ± 42 73 ± 19 155 ± 30 112 ± 42
Time to peak (min) 19.3 ± 4.8 20.3 ± 5.6 18.4 ± 3.5 20.2 ± 5.7
PPP:
Lag time (min) 2.5 ± 0.5 4.2 ± 0.9 2.4 ± 0.4 2.6 ± 0.6
ETP (nM*min) 1587 ± 355 1508 ± 297 1774 ± 279 1412 ± 336
Peak (nM) 321 ± 63 241 ± 36 350 ± 48 295 ± 64
Time to peak (min) 4.7 ± 0.7 6.7 ± 1.1 4.6 ± 0.4 4.8 ± 0.9
Data shown are mean ± SD. Comparison between the groups was done with stude
under the curve, ETP endogenous thrombin potential, PPP platelet poor plasma, PRPdifference between the groups was only found for platelet
number (p=0.002) with lower platelet count in group 2.
Differences were also seen for fibrinogen and D-dimers
with lower mean values in the group with blood loss ≥930
ml, but only the difference in fibrinogen at T2 achieved
statistical significance (p=0.045). Furthermore, it can also
be observed that patients with high blood loss had signifi-
cantly lower haematocrit (%) at T2.
The highest AUC values were observed for platelet
number with an AUC (95% CI) of 0.834 (0.690-0.979) at
T1 and an AUC (95% CI) of 0.857 (0.705-1.009) at T2. It
can also be observed that the AUC of haemoglobin and
haematocrit is higher at T2 than at T1 with AUC (95% CI)
of 0.714 (0.517-0.912); and 0.732 (0.540-0.924), respect-
ively. AUCs for these parameters at T1 are low. The AUCs
associated with fibrinogen and d-dimers are not impres-
sive at both time points with AUCs ranging from 0.547 to
0.703, and the AUC of the variables, aPTT, PT and ACT
are below 0.500.
Independent effects of platelet count and CAT
parameters
A multivariate linear regression model with both platelet
count and ETP/peak as independent variables and blood
loss as dependent variable was performed to evaluate the
independent effects of TG parameters after adjustment
for differences in platelet count between group 1 and 2.
These analyses indicate that higher values of CAT pa-
rameters remain associated with lower blood loss.
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Figure 1 ETP on T1 in PRP and PPP in both groups. Boxplot showing median, interquartile range and range of ETP measured before
heparinisation in patients of group 1 and 2 on x-axis. P-value of comparison of ETP in PRP between the groups is <0.001, p-value of comparison






































Figure 2 Peak thrombin on T1 in PRP and PPP in both groups. Boxplot showing median, interquartile range and range of peak thrombin
measured before heparinisation in patients of group 1 and 2 on x-axis. P-value of comparison of peak thrombin in PRP between the groups is
0.004, p-value of comparison of peak thrombin in PPP between the groups is 0.014; PPP=platelet poor plasma; PRP=platelet rich plasma.
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Table 3 Laboratory parameters on T1 and T2, and their association with postoperative blood loss





























D-dimers (ng/ml) 700 ± 782 1109 ±
1146




















Data shown are mean ± SD. Comparison between the groups was done with student t-test. T1 before heparinisation, T2 after protamine administration,
ACT activated clotting time, aPTT activated partial thromboplastin time, PT prothrombin time.
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are similar.
Discussion
The present data suggest that the CAT variables ETP
and peak thrombin correlate well with the clinically
observed bleeding tendency postoperatively in cardiac
surgical patients. Patients of group 2 had a significantly
lower ETP and peak thrombin, both pre (PRP and PPP)
and post CPB (only PRP), than patients in group 1.
Concerning the other laboratory parameters, platelet
number was the only individual variable measured
pre-CPB predicting blood loss postoperatively. Post CPB,
besides low fibrinogen a low platelet number was also
predictive for blood loss.
Recently Coakley and co-workers demonstrated that
TG both pre- and postoperatively could potentially be
used to identify patients at an increased risk of bleeding
post-CPB [2]. However, they only measured TG in PPP,
excluding the influence of platelets, which play a very
important role in maintaining normal haemostatic func-
tion. It is more representative of the in vivo situation to
include the procoagulant functions of platelets [10].Table 4 Independent effects of platelets and ETP in PRP on b
Univariate
B Unstandardized B Standardized
ETP (nM* min) −0.429 −0.401
Platelet number (*109/l) −2.223 −0.354
B regression coefficient, ETP endogenous thrombin potential.Conventional clot-based methods, have the disadvantage
of measuring only the moment of clot formation and en-
suing changes in the properties of the clot. Clot formation
is only one of the many functions of thrombin and not ne-
cessarily the most important one. Thrombin also activates
platelets, and furthermore, besides procoagulant effects it
has also anticoagulant effects following its binding to
thrombomodulin. Ex vivo TG tests, like CAT, measure the
haemostatic function of the blood, determined by simul-
taneous prothrombin activation and thrombin inactivation
[9]: it measures the remaining capacity of blood to
generate a thrombin burst indicating an increased risk of
thrombosis or bleeding [11]. In contrast, in vivo TG,
revealed by products like prothrombin fragment F1+2,
thrombin antithrombin complex, and d-dimers, provides
indications of TG that has already occurred [12] at the
moment of blood collection.
Since the lag time represents the same aspect as in
standard coagulation assays, this is comparable with aPTT
and PT. Our results showed that both aPTT and PT as
well as lag time were not different between the groups.
These tests terminate with endpoints that occur with less
than 5% of the reaction complete [13]. Apparently, thelood loss by linear regression analysis
Multivariate
p-value B Unstandardized B Standardized p-value
0.031 −0.322 −0.301 0.144
0.060 −1.325 −0.211 0.301
Table 5 Independent effects of platelets and peak-thrombin in PRP on blood loss by linear regression analysis
Univariate Multivariate
B Unstandardized B Standardized p-value B Unstandardized B Standardized p-value
Peak (nM) −0.2897 −0.319 0.092 −2.026 −0.223 0.253
Platelet number (*109/l) −2.223 −0.354 0.060 −1.737 −0.276 0.159
B regression coefficient.
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ation phase of clotting but the propagation phase that de-
termines haemostasis and blood loss after cardiac surgery.
Time to peak, also a time dependent variable, also did
not show any significance in predicting blood loss. Peak
thrombin and ETP, reflecting the amount of thrombin
generated, give a more accurate evaluation of coagulability.
In group 2, patients had a lower mean platelet number
both before heparinisation and after protamine adminis-
tration. Platelets are important in the blood coagulation
process and play an important role in TG by providing a
procoagulant membrane surface, and hence supporting
the formation of more thrombin [14]. We observed in
this study that reduced platelet count was also predictive
of blood loss although the latter outcome occurs within
the normal ranges of platelet count. It is worth noting
however that platelet count cannot detect abnormality
in the coagulation system. CAT, in contrast, is a global
functional test that reflects the coagulation profile of the
patient in the absence and presence of platelets. Bleeding
tendency is related to the hemostatic conditions in pro-
and anticoagulant factors, platelets, vessel wall and the
fibrinolytic system. TG in PRP reflects the major part of
this physiological clotting system, including the inter-
action between platelets and the clotting system.
Concerning coagulation factors we only measured
fibrinogen. This factor demonstrated to be higher both
pre- and postoperatively in group 1, but the difference was
only statistically significant postoperatively. In the study of
Coakley [2] coagulation factor levels were determined
postoperatively in groups that either bled more than 1L or
less than 1L. Fibrinogen level was the same in both
groups, in contrast with our results. Karlsson et al. [15]
investigated the relationship between preoperative fibrino-
gen plasma concentration and postoperative bleeding after
CABG surgery. Their main finding was that higher
preoperative fibrinogen was correlated with less blood loss
postoperatively. Despite of the important contribution of
fibrinogen in the coagulation process, our study results
indicate that fibrinogen level is less strongly associated
with blood loss than TG parameters. This is remarkable
because, although fibrinogen is depleted before 5% of all
thrombin is formed [11], thrombin bound to fibrin has a
positive feedback activation on the coagulation system
and is protected from inactivation to the action of anti-
thrombin and heparin [16].Remarkable is the significantly higher dose of intra-
operative heparin in group 1. Most probably a higher dose
of heparin is administered in this group as a result of a
relatively high platelet count in this group [17]: the con-
centration of heparin required to inhibit or delay coagula-
tion is directly related to the number of platelets [18],
probably due to the capacity of platelet released platelet
factor 4 neutralizing heparin [19,20].
Patients who bled more, were administered propor-
tionally less crystalloids and more colloids. Colloids are
known to affect clot formation by reducing fibrinogen
concentration and disturbing fibrin polymerization [21]
demonstrated by thromboelastography assay. Schols
et al. found that colloids reduce the formation of fibrin
clots but affect TG only at clinically irrelevant high con-
centrations [22]. The volume of colloids administered
was not significantly different between the groups.
Group 2 is characterized by a higher supplementation
of transfusion products. In addition, these patients had a
higher intraoperative blood loss, as shown by a higher
amount of PRC volume processed by cell salvage.
Despotis et al. also demonstrated that greater volumes
of intraoperative salvaged red cells were associated with
excessive blood loss and use of blood products [23],
explained by the fact that greater volumes of salvaged
red cells primarily reflects excessive blood loss intraope-
ratively but proceeding postoperatively. Another explan-
ation may be that extensive intraoperative cell salvage
caused a significant loss of platelets and plasma resulting
in postoperative bleeding.
The strength of this study is that CAT, performed pre-
operatively, is able to predict blood loss after cardiac
surgery. Preoperative measurements (T1) exclude the
haemostatic effects caused by exposure of the blood to
different non-physiological conditions. The predictive
value of CAT performed postoperatively (T2) for blood
loss will be influenced by a lot of interventions like hep-
arinisation, fluid administration (crystalloid and/or col-
loid), administration of tranexamic acid and protamine,
time on bypass, and transfusion product requirements
intraoperatively. All these factors interfere at different
levels in the haemostatic balance of the patients what
makes the prediction of blood loss by CAT parameters
weaker at T2 (AUCs are lower at T2).
The main limitation of the study is the low number of
participants (n=30). P-values in the multivariate linear
Bosch et al. Journal of Cardiothoracic Surgery 2013, 8:154 Page 8 of 9
http://www.cardiothoracicsurgery.org/content/8/1/154regression models were higher or even no longer statisti-
cally significant, possibly due to small sample size. The
results should be considered as preliminary. Changes in
haemostatic factors would have been more reliable in a
larger number of patients. Another limitation of the
study is that it could not account for variations in rou-
tine practice in the ICU that may have influenced blood
loss, such as amount and timing of platelet and plasma
transfusions. Especially in the bleeding group the amount
of blood loss should be influenced by platelet and plasma
transfusion. Therefore, additional larger clinical, and
preferable intervention, studies are required to establish
profound clinical relevance.
Conclusions
The key finding is that the Calibrated Automated Throm-
bography assay, performed preoperatively, provides infor-
mation predictive for non-surgical blood loss after cardiac
surgery, and might be considered as a standard screening
test to assess the haemostatic condition preoperatively.
Improved haemostatic management of patients undergo-
ing cardiac surgery, especially high risk patients, requires
more knowledge on the changes in TG, and on proactive
interventions like administration of haemostatic-augmenting
pharmacologic agents or blood components. Identifying
patients at increased risk of bleeding will become easier
because techniques for measuring TG in whole blood as a
bedside method are in development, so that the outcome
of a study with the CAT can, in the future, be more easily
applied in clinical settings.
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